SMARCB1 and osteosarcoma: Nevertheless, the study raises important aspects, and the increased number of cores used by Guo et al. in their study may consolidate the conviction that further studies are necessary to evaluate properly SMARCB1 expression with the response to chemotherapy and prognosis in osteosarcoma patients.